A randomized, double - blind, placebo - controlled trial published in the Journal of Clinical Nutrition found that taking melatonin (10 mg daily) for 12 weeks lowered biomarkers of oxidative stress and cardio - metabolic risk in type 2
diabetic patients with coronary heart disease.
Michael Oliver, a former professor for metabolic research in London was one of the first to demonstrate that, on average,
patients with coronary heart disease more often had abnomal levels of various fats in the blood than healthy individuals did.
Raygan F, Ostadmohammadi V, Bahmani F. Melatonin administration (10 mg for 12 weeks) lowers biomarkers of oxidative stress and cardio - metabolic risk in type 2
diabetic patients with coronary heart disease: A randomized, double - blind, placebo - controlled trial.
Health professionals should routinely include screening for mental distress in the care provided to
patients with coronary heart disease, he suggests.
In 2005, a trial was conducted on 45
patients with coronary heart disease.
Low levels of omega - 3 fatty acids has been found to correlate with higher death rates in
patients with coronary heart disease.
Randomised trial of cholesterol lowering in 4444
patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
Myeloperoxidase and High - Sensitivity C - Reactive Protein for Predicting Major Adverse Cardiovascular Events in Patients with Coronary Heart Disease